Store at 20° to 25°C (68° to 77°F); Protect from light
25/Bx
Manufacturer
Hikma
Size
1 mL
Sold By
Case of 25
How does Promethazine 25 mg/mL Ampule fit into treatment protocols for nausea compared to oral alternatives?
Promethazine 25 mg/mL Ampule is typically used in settings where rapid onset of action is required or when oral administration is not feasible due to vomiting or patient non-compliance. [Manufacturer Info]
Are there specific side effects associated with administering Promethazine via IV that I should watch for during patient care?
When administering Promethazine via IV, watch for potential severe reactions such as tissue damage, including gangrene, particularly if the drug extravasates; therefore, it must be administered carefully to avoid this risk. [Manufacturer Info][Industry Standards]
In what clinical situations would administering Promethazine via deep IM be preferred over IV infusion?
Administering Promethazine via deep IM might be preferred over IV infusion in situations where vein access is difficult or to avoid the risks of severe IV-related adverse effects like phlebitis. [Manufacturer Info][Industry Standards]
When using this medication for the first time in a hospital setting, what should clinicians be aware of to ensure patient safety?
Clinicians should be aware of the correct administration techniques, potential side effects, and the importance of monitoring the patient closely after administration to ensure safety. [Manufacturer Info]
How should I ensure proper storage and handling of the ampules to maintain their efficacy and integrity?
Store the ampules at 20° to 25°C (68° to 77°F) and protect them from light to maintain their efficacy and integrity. [Product Specs]
Is there any preparation needed before administering this as an IV infusion to a patient in an emergency room?
Before administering Promethazine as an IV infusion, ensure dilution in a compatible fluid and check for particulate matter and discoloration to ensure solution integrity. [Manufacturer Info]
If I'm considering switching to this product from another antinausea medication, what differences might I notice in terms of patient response?
When switching to Promethazine, you may notice a quicker onset of action and potential differences in side effect profiles compared to oral antinausea medications. [Manufacturer Info]
What precautions should be taken to protect the ampules from light exposure during storage and transport?
Protect the ampules from light exposure by storing them in opaque, light-resistant containers during storage and transport. [Product Specs]
Could you explain why this might not be a suitable option for treating patients with severe hepatic impairment?
Promethazine may not be suitable for patients with severe hepatic impairment due to its extensive metabolism in the liver, potentially leading to exacerbated side effects and toxicity. [Manufacturer Info]
HikmaItem # Dealmed item number: 149569MPN Manufacturer part number: 00641-1495-35
Store at 20° to 25°C (68° to 77°F); Protect from light
25/Bx
Manufacturer
Hikma
Size
1 mL
Sold By
Case of 25
How does Promethazine 25 mg/mL Ampule fit into treatment protocols for nausea compared to oral alternatives?
Promethazine 25 mg/mL Ampule is typically used in settings where rapid onset of action is required or when oral administration is not feasible due to vomiting or patient non-compliance. [Manufacturer Info]
Are there specific side effects associated with administering Promethazine via IV that I should watch for during patient care?
When administering Promethazine via IV, watch for potential severe reactions such as tissue damage, including gangrene, particularly if the drug extravasates; therefore, it must be administered carefully to avoid this risk. [Manufacturer Info][Industry Standards]
In what clinical situations would administering Promethazine via deep IM be preferred over IV infusion?
Administering Promethazine via deep IM might be preferred over IV infusion in situations where vein access is difficult or to avoid the risks of severe IV-related adverse effects like phlebitis. [Manufacturer Info][Industry Standards]
When using this medication for the first time in a hospital setting, what should clinicians be aware of to ensure patient safety?
Clinicians should be aware of the correct administration techniques, potential side effects, and the importance of monitoring the patient closely after administration to ensure safety. [Manufacturer Info]
How should I ensure proper storage and handling of the ampules to maintain their efficacy and integrity?
Store the ampules at 20° to 25°C (68° to 77°F) and protect them from light to maintain their efficacy and integrity. [Product Specs]
Is there any preparation needed before administering this as an IV infusion to a patient in an emergency room?
Before administering Promethazine as an IV infusion, ensure dilution in a compatible fluid and check for particulate matter and discoloration to ensure solution integrity. [Manufacturer Info]
If I'm considering switching to this product from another antinausea medication, what differences might I notice in terms of patient response?
When switching to Promethazine, you may notice a quicker onset of action and potential differences in side effect profiles compared to oral antinausea medications. [Manufacturer Info]
What precautions should be taken to protect the ampules from light exposure during storage and transport?
Protect the ampules from light exposure by storing them in opaque, light-resistant containers during storage and transport. [Product Specs]
Could you explain why this might not be a suitable option for treating patients with severe hepatic impairment?
Promethazine may not be suitable for patients with severe hepatic impairment due to its extensive metabolism in the liver, potentially leading to exacerbated side effects and toxicity. [Manufacturer Info]
Promethazine Hydrochloride
25 mg/mL
1 mL Ampuls
NDC 0641-1495-35
Deep IM or IV Infusion
Store at 20° to 25°C (68° to 77°F); Protect from light
25/Bx
Manufacturer
Hikma
Size
1 mL
Sold By
Case of 25
How does Promethazine 25 mg/mL Ampule fit into treatment protocols for nausea compared to oral alternatives?
Promethazine 25 mg/mL Ampule is typically used in settings where rapid onset of action is required or when oral administration is not feasible due to vomiting or patient non-compliance. [Manufacturer Info]
Are there specific side effects associated with administering Promethazine via IV that I should watch for during patient care?
When administering Promethazine via IV, watch for potential severe reactions such as tissue damage, including gangrene, particularly if the drug extravasates; therefore, it must be administered carefully to avoid this risk. [Manufacturer Info][Industry Standards]
In what clinical situations would administering Promethazine via deep IM be preferred over IV infusion?
Administering Promethazine via deep IM might be preferred over IV infusion in situations where vein access is difficult or to avoid the risks of severe IV-related adverse effects like phlebitis. [Manufacturer Info][Industry Standards]
When using this medication for the first time in a hospital setting, what should clinicians be aware of to ensure patient safety?
Clinicians should be aware of the correct administration techniques, potential side effects, and the importance of monitoring the patient closely after administration to ensure safety. [Manufacturer Info]
How should I ensure proper storage and handling of the ampules to maintain their efficacy and integrity?
Store the ampules at 20° to 25°C (68° to 77°F) and protect them from light to maintain their efficacy and integrity. [Product Specs]
Is there any preparation needed before administering this as an IV infusion to a patient in an emergency room?
Before administering Promethazine as an IV infusion, ensure dilution in a compatible fluid and check for particulate matter and discoloration to ensure solution integrity. [Manufacturer Info]
If I'm considering switching to this product from another antinausea medication, what differences might I notice in terms of patient response?
When switching to Promethazine, you may notice a quicker onset of action and potential differences in side effect profiles compared to oral antinausea medications. [Manufacturer Info]
What precautions should be taken to protect the ampules from light exposure during storage and transport?
Protect the ampules from light exposure by storing them in opaque, light-resistant containers during storage and transport. [Product Specs]
Could you explain why this might not be a suitable option for treating patients with severe hepatic impairment?
Promethazine may not be suitable for patients with severe hepatic impairment due to its extensive metabolism in the liver, potentially leading to exacerbated side effects and toxicity. [Manufacturer Info]
Promethazine Hydrochloride
25 mg/mL
1 mL Ampuls
NDC 0641-1495-35
Deep IM or IV Infusion
Store at 20° to 25°C (68° to 77°F); Protect from light
25/Bx
Manufacturer
Hikma
Size
1 mL
Sold By
Case of 25
How does Promethazine 25 mg/mL Ampule fit into treatment protocols for nausea compared to oral alternatives?
Promethazine 25 mg/mL Ampule is typically used in settings where rapid onset of action is required or when oral administration is not feasible due to vomiting or patient non-compliance. [Manufacturer Info]
Are there specific side effects associated with administering Promethazine via IV that I should watch for during patient care?
When administering Promethazine via IV, watch for potential severe reactions such as tissue damage, including gangrene, particularly if the drug extravasates; therefore, it must be administered carefully to avoid this risk. [Manufacturer Info][Industry Standards]
In what clinical situations would administering Promethazine via deep IM be preferred over IV infusion?
Administering Promethazine via deep IM might be preferred over IV infusion in situations where vein access is difficult or to avoid the risks of severe IV-related adverse effects like phlebitis. [Manufacturer Info][Industry Standards]
When using this medication for the first time in a hospital setting, what should clinicians be aware of to ensure patient safety?
Clinicians should be aware of the correct administration techniques, potential side effects, and the importance of monitoring the patient closely after administration to ensure safety. [Manufacturer Info]
How should I ensure proper storage and handling of the ampules to maintain their efficacy and integrity?
Store the ampules at 20° to 25°C (68° to 77°F) and protect them from light to maintain their efficacy and integrity. [Product Specs]
Is there any preparation needed before administering this as an IV infusion to a patient in an emergency room?
Before administering Promethazine as an IV infusion, ensure dilution in a compatible fluid and check for particulate matter and discoloration to ensure solution integrity. [Manufacturer Info]
If I'm considering switching to this product from another antinausea medication, what differences might I notice in terms of patient response?
When switching to Promethazine, you may notice a quicker onset of action and potential differences in side effect profiles compared to oral antinausea medications. [Manufacturer Info]
What precautions should be taken to protect the ampules from light exposure during storage and transport?
Protect the ampules from light exposure by storing them in opaque, light-resistant containers during storage and transport. [Product Specs]
Could you explain why this might not be a suitable option for treating patients with severe hepatic impairment?
Promethazine may not be suitable for patients with severe hepatic impairment due to its extensive metabolism in the liver, potentially leading to exacerbated side effects and toxicity. [Manufacturer Info]
:fill(white)/catsy.939/Hikma 6083-25.jpg/rename/Hikma 6083-25.webp)
:fill(white)/catsy.939/665326_front.jpg/rename/665326_front.webp)
:fill(white)/catsy.939/1744e36b-9e6d-46c1-9131-9b859267d593.jpeg/rename/1744e36b-9e6d-46c1-9131-9b859267d593.webp)
:fill(white)/catsy.939/30734d3d-1413-4a79-ae7c-fda9f9a6b016.jpeg/rename/30734d3d-1413-4a79-ae7c-fda9f9a6b016.webp)